Chary Akmyradov

Dr. Chary Akmyradov

Biostatistics, Children's Nutrition Research Center at Baylor College of Medicine, Houston, Texas, USA
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2022 in Hospital Pediatrics
Verified
Journal Article
Closed access
PDF file
CCCourtney Cox
Courtney Cox
KPKrishna Patel
Krishna Patel
RCRebecca Cantu
Rebecca Cantu
Chary AkmyradovChary Akmyradov
Chary Akmyradov
KIKatherine Irby
Katherine Irby
Status asthmaticus is commonly treated in pediatric patients by using continuous albuterol, which can cause hypokalemia. The primary aim of this study was to determine if serial potassium monitoring is necessary by examining treatment frequency of hypokalemia. This retrospective analysis was performed in 185 pediatric patients admitted with status asthmaticus requiring continuous albuterol between 2017 and 2019. All patients were placed on intravenous fluids containing potassium. The primary outcome measure was the treatment of hypokalemia in relation to the number of laboratory draws for potassium levels. The secondary outcome measure was hypokalemia frequency and relation to the duration and initial dose of continuous albuterol. Included were 156 patients with 420 laboratory draws (average, 2.7 per patient) for potassium levels. The median lowest potassium level was 3.40 mmol/L (interquartile range, 3.2–3.7). No correlation was found between initial albuterol dose and lowest potassium level (P = .52). Patients with hypokalemia had a mean albuterol time of 12.32 (SD, 15.76) hours, whereas patients without hypokalemia had a mean albuterol time of 11.50 (SD, 12.53) hours (P = .29). Potassium levels were treated 13 separate times. The number of laboratory draws for potassium levels was high in our cohort, with few patients receiving treatment for hypokalemia beyond the potassium routinely added to maintenance fluids. Length of time on albuterol and dose of albuterol were not shown to increase the risk of hypokalemia. Serial laboratory measurements may be decreased to potentially reduce health care costs, pain, and anxiety surrounding needlesticks.

1 January 2022 in The Journal of Pediatrics
Verified
Journal Article
Closed access
NENahed O. ElHassan
Nahed O. ElHassan
MSMegha Sharma
Megha Sharma
Chary AkmyradovChary Akmyradov
Chary Akmyradov
JKJeffrey R. Kaiser
Jeffrey R. Kaiser
AGAnthony Goudie
Anthony Goudie
WNWendy N. Nembhard
Wendy N. Nembhard

19 October 2022 in Birth Defects Research
Verified
Journal Article
Closed access
AWAlyssa R. Walden
Alyssa R. Walden
WNWendy N. Nembhard
Wendy N. Nembhard
Chary AkmyradovChary Akmyradov
Chary Akmyradov
AGAnthony Goudie
Anthony Goudie
NENahed O. ElHassan
Nahed O. ElHassan

29 May 2021 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
LSLaura Schoeneberg
Laura Schoeneberg
PPParthak Prodhan
Parthak Prodhan
BSBeverly Spray
Beverly Spray
Chary AkmyradovChary Akmyradov
Chary Akmyradov
DZDala Zakaria
Dala Zakaria

21 December 2023 in Journal of Perinatology
Verified
Journal Article
Closed access
PDF file
ALAshley L. Lynch
Ashley L. Lynch
DMDavid N. Matlock
David N. Matlock
Chary AkmyradovChary Akmyradov
Chary Akmyradov
MWMichael D. Weisner
Michael D. Weisner
JBJennifer C. Beck
Jennifer C. Beck
SCSherry E. Courtney
Sherry E. Courtney

27 May 2025 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
ZGZena Ghazala
Zena Ghazala
MPMatthew Pertzborn
Matthew Pertzborn
MFMacey Feimster
Macey Feimster
Chary AkmyradovChary Akmyradov
Chary Akmyradov
JMJoana Mack
Joana Mack
ABAriel Berlinski
Ariel Berlinski